ICD-10 Code C94.21 | Acute megakaryoblastic leukemia, in remission Symptoms, Diagnosis, Billing

Acute megakaryoblastic leukemia (AMKL) is a rare form of acute leukemia characterized by the proliferation of megakaryoblasts in the bone marrow. It is often associated with genetic mutations and can occur in both children and adults. The remission status indicates that the disease is currently not active, which is crucial for treatment planning and monitoring. ICD-10 Code C94.21 facilitates accurate diagnosis, documentation, and billing, ensuring compliance with healthcare regulations and supporting public health data collection.

What is ICD-10 Code C94.21 for Acute megakaryoblastic leukemia, in remission?

ICD-10 Code C94.21 specifically denotes Acute megakaryoblastic leukemia in remission. This code is used when a patient has been diagnosed with AMKL but is currently in a state of remission, meaning there are no active signs of the disease. It is essential for clinical documentation and billing to reflect the patient's current health status accurately, ensuring appropriate treatment and follow-up care.

ICD-10 Code C94.21 – Clinical Definition and Explanation of Acute megakaryoblastic leukemia, in remission

Acute megakaryoblastic leukemia is a hematological malignancy that arises from the abnormal proliferation of megakaryoblasts. The condition can progress rapidly and requires immediate medical intervention. Remission indicates a favorable response to treatment, necessitating ongoing monitoring and supportive care.

Key Clinical Features:

• Presence of megakaryoblasts in bone marrow
• Symptoms may include fatigue, bleeding, and bruising
• Typically diagnosed through blood tests and bone marrow biopsy
• Requires regular follow-up to monitor for relapse

ICD-10 Code C94.21 for Acute megakaryoblastic leukemia, in remission – SOAP Notes & Clinical Use

In SOAP notes, ICD-10 Code C94.21 is utilized to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a critical role in capturing the patient's clinical picture, ensuring accurate billing, and facilitating communication among healthcare providers.

What Does ICD-10 Code C94.21 for Acute megakaryoblastic leukemia, in remission Mean in SOAP Notes?

ICD-10 Code C94.21 connects subjective patient reports and objective clinical findings to a formal diagnosis of AMKL in remission. This code is vital for maintaining continuity of care, supporting accurate billing practices, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C94.21 – Acute megakaryoblastic leukemia, in remission

Management of Acute megakaryoblastic leukemia in remission focuses on monitoring and supportive care to prevent relapse.

Antibiotic Therapy:

• Not typically indicated unless infection occurs; consider prophylactic antibiotics in high-risk patients.
• First-line: Ceftriaxone, duration based on clinical response.
• Alternative: Vancomycin for resistant organisms, duration based on clinical response.

Supportive Care:

• Regular blood transfusions to manage anemia and thrombocytopenia.
• Growth factor support (e.g., G-CSF) to stimulate bone marrow recovery.
• Psychosocial support and counseling for patients and families.

Infection Control:

• Strict hand hygiene practices to prevent infections.
• Isolation precautions if neutropenic.
• Vaccination updates as per guidelines.

How to Document Symptoms of Acute megakaryoblastic leukemia, in remission (ICD-10 C94.21) in SOAP Notes

Subjective:

• Patient reports fatigue and occasional bruising.
• No recent episodes of bleeding or infections.
• Denies fever or chills.
• Patient expresses concern about potential relapse.

Objective:

• Complete blood count shows normal platelet levels.
• Bone marrow biopsy indicates no evidence of leukemic cells.
• Vital signs stable: BP 120/80, HR 72, Temp 98.6°F.
• Physical exam reveals no signs of active disease.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Acute megakaryoblastic leukemia, in remission (ICD-10 Code C94.21)

Assessment:

• Diagnosis: Acute megakaryoblastic leukemia, in remission, C94.21.
• Severity: Currently stable with no active disease.
• Triggers: Previous chemotherapy and genetic predisposition.

Plan:

• Continue regular follow-up appointments every 3 months.
• Monitor blood counts and perform bone marrow biopsy as needed.
• Educate patient on signs of relapse and when to seek care.
• Consider referral to a hematologist for ongoing management.

Treatment & Plan Section for ICD-10 Code C94.21 – Acute megakaryoblastic leukemia, in remission

• Monitor blood counts regularly to detect any signs of relapse.
• Educate the patient on maintaining a healthy lifestyle to support recovery.
• Implement a follow-up schedule to ensure timely assessments.
• Consider psychological support services for coping with the diagnosis.

Using ICD-10 Code C94.21 for Acute megakaryoblastic leukemia, in remission in Billing & SOAP Note Compliance

• Ensure accurate documentation of remission status in the patient's chart.
• Use C94.21 in conjunction with other relevant codes for comprehensive billing.
• Document all clinical findings clearly to support the diagnosis and treatment plan.
• Align treatment plans with clinical guidelines to justify billing and reimbursement.

Related ICD-10 Codes Often Used with Acute megakaryoblastic leukemia, in remission

• C94.22 – Acute megakaryoblastic leukemia, not in remission
• C92.40 – Acute myeloid leukemia, unspecified
• C91.00 – Acute lymphoblastic leukemia, unspecified

ICD-10 Code C94.21 in Medical Billing and Insurance for Acute megakaryoblastic leukemia, in remission

ICD-10 Code C94.21 is crucial for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document the patient's remission status clearly to support claims.
• Use C94.21 in conjunction with treatment codes for comprehensive billing.
• Ensure all relevant clinical information is included in the patient's chart.

Common CPT Pairings: